The third generation oral contraceptive controversy. The evidence shows they are less safe than second generation pills

Editorial

P A O'Brien. BMJ. 1999.

. 1999 Sep 25;319(7213):795-6.

doi: 10.1136/bmj.319.7213.795.

No abstract available

Comment in

Competing interests and controversy about third generation oral contraceptives. BMJ readers should know whose words they read.
Vandenbroucke JP, Helmerhorst FM, Rosendaal FR. Vandenbroucke JP, et al. BMJ. 2000 Feb 5;320(7231):381-2. BMJ. 2000. PMID: 10657348 Free PMC article. No abstract available.
Competing interests and controversy about third generation oral contraceptives. Science is not a dispassionate activity.
Hannaford P. Hannaford P. BMJ. 2000 Feb 5;320(7231):382. BMJ. 2000. PMID: 10712031 No abstract available.

Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark, 1977-95.
Mellemkjaer L, Sørensen HT, Dreyer L, Olsen J, Olsen JH. Mellemkjaer L, et al. BMJ. 1999 Sep 25;319(7213):820-1. doi: 10.1136/bmj.319.7213.820. BMJ. 1999. PMID: 10496825 Free PMC article. No abstract available.

1. Medicines Commission. Combined oral contraceptives containing desogestrel or gestodene and the risk of venous thromboembolism. Current Problems in Pharmacovigilance. 1999;25:12.
1. Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception. 1997;56:129–140. - PubMed
1. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet. 1997;349:1202–1209. - PubMed
1. Dunn N, Thorogood M, Faragher B, de Caestecker L, MacDonald TM, McCollum C, et al. Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ. 1999;318:1579–1584. - PMC - PubMed
1. Bloemenkamp K, Rosendaal F, Helmerhorst F, Buller H, Vandenbrouke J. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestogen. Lancet. 1995;346:1593–1596. - PubMed